Update: 26.12.2022
Last week: 50 week 2022 (12.12.2022 - 18.12.2022)
Last full month: November 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 228 256 | 1.4% | 3.2% | -0.2 | 54 410 862 | 4.5% | 3.4% | -0.1 | 7.2% |
| MoM | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| YTD | 9 500 598 | -25.3% | 4.9% | -1.5 | 1 933 374 836 | -11.6% | 4.8% | -1 | -2.4% |
| MAT | 10 050 534 | -22.5% | 4.9% | -1.2 | 2 036 308 636 | -8.9% | 4.8% | -0.8 | -4.0% |
| DEXALGIN | |||||||||
| WoW | 19 332 | 6.5% | 0.3% | 0 | 9 141 958 | 6.8% | 1.0% | 0 | 5.4% |
| MoM | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| YTD | 1 542 785 | -12.3% | 0.6% | -0.1 | 665 424 741 | -0.7% | 1.7% | -0.2 | -0.4% |
| MAT | 1 622 132 | -12.6% | 0.6% | -0.1 | 696 478 165 | -1.3% | 1.7% | -0.2 | -2.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 55 922 | -1.6% | 42.0% | 0.3 | 32 850 905 | 1.4% | 50.4% | 2.1 | -2.3% |
| MoM | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| YTD | 4 180 189 | -17.8% | 53.5% | -12.7 | 2 146 027 982 | -8.0% | 59.2% | -11.4 | 1.6% |
| MAT | 4 374 800 | -18.3% | 53.8% | -12.2 | 2 239 198 140 | -8.4% | 59.5% | -10.9 | 0.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 291 | -6.1% | 31.0% | -0.6 | 15 873 323 | -4.4% | 46.5% | -0.4 | -4.2% |
| MoM | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| YTD | 1 383 120 | -13.9% | 37.2% | -4.3 | 874 331 976 | -6.8% | 50.5% | -5.7 | -4.0% |
| MAT | 1 440 264 | -15.6% | 37.2% | -4.2 | 907 990 514 | -8.7% | 50.6% | -5.6 | -6.0% |
| FASTUM | |||||||||
| WoW | 15 955 | 6.6% | 0.9% | 0.1 | 9 238 453 | 10.2% | 2.3% | 0.2 | 0.4% |
| MoM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| YTD | 1 011 157 | -24.6% | 1.1% | -0.4 | 529 691 402 | -14.4% | 2.5% | -0.6 | -0.0% |
| MAT | 1 055 331 | -25.8% | 1.1% | -0.4 | 550 985 694 | -15.9% | 2.5% | -0.6 | -1.8% |
| IODOMARIN | |||||||||
| WoW | 67 515 | -4.4% | 21.1% | -1.4 | 12 375 184 | -4.8% | 8.3% | -0.9 | 2.0% |
| MoM | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| YTD | 3 170 950 | 4.6% | 20.5% | 0 | 617 523 655 | 8.8% | 9.1% | -0.2 | 4.5% |
| MAT | 3 304 838 | 5.2% | 20.6% | 0.5 | 642 140 456 | 9.0% | 9.2% | 0 | 2.9% |
| LIOTON | |||||||||
| WoW | 16 806 | 20.5% | 1.7% | 0.3 | 20 730 852 | 30.9% | 4.6% | 1 | 1.2% |
| MoM | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| YTD | 1 222 865 | -25.7% | 2.2% | -0.5 | 1 273 250 817 | -6.5% | 4.6% | -1 | -7.6% |
| MAT | 1 269 882 | -26.3% | 2.2% | -0.5 | 1 314 688 726 | -7.4% | 4.6% | -0.9 | -8.9% |
| MEZYM | |||||||||
| WoW | 224 716 | 2.4% | 17.8% | 0.1 | 33 590 213 | 3.1% | 12.3% | -0.1 | 1.9% |
| MoM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| YTD | 16 824 921 | -15.3% | 25.6% | -3.4 | 2 566 383 971 | -7.6% | 18.3% | -3.4 | -4.1% |
| MAT | 17 713 845 | -16.0% | 25.8% | -3.2 | 2 697 094 013 | -8.4% | 18.5% | -3.2 | -5.6% |
| MIG 400 | |||||||||
| WoW | 151 280 | 4.6% | 2.4% | 0 | 18 433 747 | 5.8% | 2.0% | 0 | 5.4% |
| MoM | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| YTD | 8 108 224 | -15.2% | 3.2% | -0.6 | 958 101 998 | -11.2% | 2.5% | -0.6 | -0.4% |
| MAT | 8 439 492 | -16.0% | 3.2% | -0.5 | 996 222 123 | -12.1% | 2.5% | -0.6 | -2.3% |
| PROSTAMOL | |||||||||
| WoW | 24 089 | 1.0% | 13.6% | 0.3 | 33 874 253 | 3.6% | 14.8% | 0.8 | -1.4% |
| MoM | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| YTD | 1 502 789 | -27.4% | 18.3% | -6.4 | 2 102 815 300 | -19.4% | 19.5% | -7.3 | -2.1% |
| MAT | 1 573 219 | -27.9% | 18.5% | -6.1 | 2 195 421 428 | -19.9% | 19.7% | -7 | -4.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 40 736 | 9.8% | 8.3% | 0.5 | 20 930 530 | 11.4% | 9.0% | 0.5 | 3.4% |
| MoM | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
| YTD | 1 228 450 | 77.9% | 8.3% | 3.4 | 584 441 481 | 82.4% | 8.4% | 3.2 | 5.5% |
| MAT | 1 284 538 | 80.1% | 8.3% | 3.5 | 608 964 517 | 84.0% | 8.4% | 3.3 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 500 598 | -25.3% | 4.9% | -1.5 | 1 933 374 836 | -11.6% | 4.8% | -1 | -2.4% |
| DEXALGIN | 1 542 785 | -12.3% | 0.6% | -0.1 | 665 424 741 | -0.7% | 1.7% | -0.2 | -0.4% |
| ESPUMISAN (ADULTS) | 4 180 189 | -17.8% | 53.5% | -12.7 | 2 146 027 982 | -8.0% | 59.2% | -11.4 | 1.6% |
| ESPUMISAN BABY | 1 383 120 | -13.9% | 37.2% | -4.3 | 874 331 976 | -6.8% | 50.5% | -5.7 | -4.0% |
| FASTUM | 1 011 157 | -24.6% | 1.1% | -0.4 | 529 691 402 | -14.4% | 2.5% | -0.6 | -0.0% |
| IODOMARIN | 3 170 950 | 4.6% | 20.5% | 0 | 617 523 655 | 8.8% | 9.1% | -0.2 | 4.5% |
| LIOTON | 1 222 865 | -25.7% | 2.2% | -0.5 | 1 273 250 817 | -6.5% | 4.6% | -1 | -7.6% |
| MEZYM | 16 824 921 | -15.3% | 25.6% | -3.4 | 2 566 383 971 | -7.6% | 18.3% | -3.4 | -4.1% |
| MIG 400 | 8 108 224 | -15.2% | 3.2% | -0.6 | 958 101 998 | -11.2% | 2.5% | -0.6 | -0.4% |
| PROSTAMOL | 1 502 789 | -27.4% | 18.3% | -6.4 | 2 102 815 300 | -19.4% | 19.5% | -7.3 | -2.1% |
| RESPERO MYRTOL | 1 228 450 | 77.9% | 8.3% | 3.4 | 584 441 481 | 82.4% | 8.4% | 3.2 | 5.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 10 050 534 | -22.5% | 4.9% | -1.2 | 2 036 308 636 | -8.9% | 4.8% | -0.8 | -4.0% |
| DEXALGIN | 1 622 132 | -12.6% | 0.6% | -0.1 | 696 478 165 | -1.3% | 1.7% | -0.2 | -2.3% |
| ESPUMISAN (ADULTS) | 4 374 800 | -18.3% | 53.8% | -12.2 | 2 239 198 140 | -8.4% | 59.5% | -10.9 | 0.3% |
| ESPUMISAN BABY | 1 440 264 | -15.6% | 37.2% | -4.2 | 907 990 514 | -8.7% | 50.6% | -5.6 | -6.0% |
| FASTUM | 1 055 331 | -25.8% | 1.1% | -0.4 | 550 985 694 | -15.9% | 2.5% | -0.6 | -1.8% |
| IODOMARIN | 3 304 838 | 5.2% | 20.6% | 0.5 | 642 140 456 | 9.0% | 9.2% | 0 | 2.9% |
| LIOTON | 1 269 882 | -26.3% | 2.2% | -0.5 | 1 314 688 726 | -7.4% | 4.6% | -0.9 | -8.9% |
| MEZYM | 17 713 845 | -16.0% | 25.8% | -3.2 | 2 697 094 013 | -8.4% | 18.5% | -3.2 | -5.6% |
| MIG 400 | 8 439 492 | -16.0% | 3.2% | -0.5 | 996 222 123 | -12.1% | 2.5% | -0.6 | -2.3% |
| PROSTAMOL | 1 573 219 | -27.9% | 18.5% | -6.1 | 2 195 421 428 | -19.9% | 19.7% | -7 | -4.0% |
| RESPERO MYRTOL | 1 284 538 | 80.1% | 8.3% | 3.5 | 608 964 517 | 84.0% | 8.4% | 3.3 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 228 256 | 1.4% | 3.2% | -0.2 | 54 410 862 | 4.5% | 3.4% | -0.1 | 7.2% |
| DEXALGIN | 19 332 | 6.5% | 0.3% | 0 | 9 141 958 | 6.8% | 1.0% | 0 | 5.4% |
| ESPUMISAN (ADULTS) | 55 922 | -1.6% | 42.0% | 0.3 | 32 850 905 | 1.4% | 50.4% | 2.1 | -2.3% |
| ESPUMISAN BABY | 22 291 | -6.1% | 31.0% | -0.6 | 15 873 323 | -4.4% | 46.5% | -0.4 | -4.2% |
| FASTUM | 15 955 | 6.6% | 0.9% | 0.1 | 9 238 453 | 10.2% | 2.3% | 0.2 | 0.4% |
| IODOMARIN | 67 515 | -4.4% | 21.1% | -1.4 | 12 375 184 | -4.8% | 8.3% | -0.9 | 2.0% |
| LIOTON | 16 806 | 20.5% | 1.7% | 0.3 | 20 730 852 | 30.9% | 4.6% | 1 | 1.2% |
| MEZYM | 224 716 | 2.4% | 17.8% | 0.1 | 33 590 213 | 3.1% | 12.3% | -0.1 | 1.9% |
| MIG 400 | 151 280 | 4.6% | 2.4% | 0 | 18 433 747 | 5.8% | 2.0% | 0 | 5.4% |
| PROSTAMOL | 24 089 | 1.0% | 13.6% | 0.3 | 33 874 253 | 3.6% | 14.8% | 0.8 | -1.4% |
| RESPERO MYRTOL | 40 736 | 9.8% | 8.3% | 0.5 | 20 930 530 | 11.4% | 9.0% | 0.5 | 3.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| DEXALGIN | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| ESPUMISAN (ADULTS) | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| ESPUMISAN BABY | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| FASTUM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| IODOMARIN | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| LIOTON | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| MEZYM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| MIG 400 | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| PROSTAMOL | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| RESPERO MYRTOL | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs